Mycinor is indicated for the treatment of infected wounds and abscesses, and infected mouth cavity and dental infections, caused by or associated with:
- Staphylococcus spp
- Streptococcus spp (except Streptococcus Faecalis)
- Bacteroides spp
- Fusobacterium Necrophorum,
- Clostridium Perfringens
It is also for the treatment of superficial pyoderma associated with Staphylococcus intermedius and for the treatment of osteomyelitis, caused by Staphylococcus Aureus.
Each Mycinor Tablet contains 150mg Clindamycin (as Clindamycin Hydrochloride).
The tablets are circular in shape, white to off-white in colour and can be divided into equal halves for oral administration.
Tablets sold individually.
Product Expiry Date: July 2019
POM-V | Mycinor 150mg Tablets for Dogs